Would allowing pharmacists to disclose information relative to lower cost drugs. Would prevent contracts between an insurance carrier or pharmacy benefit manager and a contracted pharmacy fromcontaining a provision prohibiting divulgence to a covered person or the insurance department relative to monetary matters which would prove beneficial in lowering costs to such covered person. Would allow a pharmacist to substitute a biological product pursuant only if it has been licensed by the federal Food and Drug Administration as an interchangeable biological product for the prescribed biological product.